Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemia.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use*; D001412:Bacillus subtilis / Q000276:immunology; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use; D005260:Female; D007939:Leukemia L1210 / Q000628:therapy*; D051379:Mice; D008837:Micrococcus / Q000276:immunology*; D009368:Neoplasm Transplantation
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D001428:Bacterial Vaccines; D002330:Carmustine